#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Prodromal Alzheimer's disease Niemann-Pick disease Epidermolysis bullosa Primary myelofibrosis Systemic mastocytosis Metastases to peritoneum Burkitt's lymphoma Spinal cord injury cervical Fibrous dysplasia of bone Autoimmune demyelinating disease Autologous haematopoietic stem cell transplant Antisynthetase syndrome Myotonic dystrophy Short stature homeobox gene mutation Hereditary neuropathic amyloidosis More trials…

    Learn about Rare Diseases

    Factor VIII deficiency – Trials in Disease Myelodysplastic syndrome – Life with Disease Nodal marginal zone B-cell lymphoma – Life with Disease Primary immunodeficiency syndrome – Basic Information Cholangitis sclerosing – Diagnostics Testicular leiomyosarcoma Glomerulonephritis membranoproliferative – Basic Information Metachromatic leukodystrophy – Trials in Disease Encephalitis autoimmune – Trials in Disease Congenital hypotransferrinaemia More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Tacrolimus Cefuroxime Cytisinicline Pevonedistat Giredestrant VRDN-003 DISODIUM PHOSPHATE Nms-03592088 Sepiapterin Lenacapavir Sodium NALDEMEDINE Gadoteric Acid Ethanol (96 Per Cent) Protease Bedaquiline Rugonersen Zagociguat Edg-5506 Alnus Glutinosa Pollen Nicotine Resinate More therapies…

    Learn about Your Condition

    Cutibacterium acnes infection Intestinal ischaemia Osteomyelitis acute Ewing's sarcoma Pancreatic carcinoma Osteochondrodysplasia Pulmonary hypertension Lung disorder Lumbosacral radiculopathy Septic shock Penile squamous cell carcinoma Tricuspid valve disease Perinatal depression Behcet's syndrome Acute HIV infection More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study Comparing Chemoradiation and Chemotherapy with Cisplatin, Paclitaxel, and Carboplatin for Patients with Advanced Vulvar Cancer

    Recruiting

    4 1 1 1
    Investigated Diseases:
    • Vulval cancer
    Investigated Drugs:
    • Carboplatin
    • Cisplatin
    • Paclitaxel
    Belgium Czechia The Netherlands Spain
  • Study of BMS-986340, Nivolumab, and Docetaxel for Adults with Advanced or Metastatic Cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Neoplasm malignant
    Investigated Drugs:
    • Bms-986340
    • Docetaxel
    • Nivolumab
    Germany Italy Spain
  • Study on Treatment Options for Patients with Oligometastatic Pancreatic Cancer: Comparing Oxaliplatin, Fluorouracil, Folinic Acid, and Drug Combination

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Pancreatic carcinoma
    Investigated Drugs:
    • Fluorouracil
    • Folinic Acid
    • Irinotecan Hydrochloride Trihydrate
    Finland Germany The Netherlands Sweden
  • Long-Term Follow-Up Study for Patients Treated with Idecabtagene Vicleucel or Lisocabtagene Maraleucel for Cancer

    Recruiting

    4 1 1
    Investigated Drugs:
    • ARLOCABTAGENE AUTOLEUCEL
    • CC-97540
    • Idecabtagene Vicleucel
    Austria Belgium Czechia Denmark Finland France +11
  • Study Comparing Iberdomide and Lenalidomide for Maintenance Therapy After Stem Cell Transplant in Patients with Newly Diagnosed Multiple Myeloma

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Plasma cell myeloma
    Investigated Drugs:
    • Enoxaparin Sodium
    • Iberdomide
    • Warfarin Sodium
    Austria Belgium Czechia Denmark Finland France +10
  • Study on Fish Oil Emulsion for Preventing Atrial Fibrillation in High-Risk Cardiac Surgery Patients

    Recruiting

    2 1 1
    Investigated Diseases:
    • Critical illness
    Investigated Drugs:
    • Glycerol
    • Highly Refined Fish Oil
    • Purified Egg Phospholipids
    Germany
Previous Page
1 … 601 602 603 604 605 … 1,654
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.


European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.

Numer nieprawidłowy!
Numer nieprawidłowy!